Last reviewed · How we verify

Fentanyl,Remifentanil

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University · FDA-approved active Small molecule Quality 5/100

Fentanyl,Remifentanil is a Small molecule drug developed by Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University. It is currently FDA-approved.

At a glance

Generic nameFentanyl,Remifentanil
SponsorShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Fentanyl,Remifentanil

What is Fentanyl,Remifentanil?

Fentanyl,Remifentanil is a Small molecule drug developed by Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University.

Who makes Fentanyl,Remifentanil?

Fentanyl,Remifentanil is developed and marketed by Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University (see full Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University pipeline at /company/shanghai-ninth-people-s-hospital-affiliated-to-shanghai-jiao-tong-university).

What development phase is Fentanyl,Remifentanil in?

Fentanyl,Remifentanil is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing